Soleus Capital Management, L.P. Axogen, Inc. Transaction History

Soleus Capital Management, L.P.

$1.18 Billion
Q3 2024

A detailed history of Soleus Capital Management, L.P. transactions in Axogen, Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 3,005,943 shares of AXGN stock, worth $50.1 Million. This represents 3.58% of its overall portfolio holdings.

Number of Shares

3,005,943

Previous 3,305,815 9.07%

Holding current value

$50.1 Million

Previous $23.9 Million 76.08%

% of portfolio

3.58%

Previous 2.42%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.52 - $14.69 $2.26 Million - $4.41 Million	-299,872 Reduced 9.07%	3,005,943 $42.1 Million
Q2 2024 Aug 14, 2024	BUY	$5.67 - $8.06 $1.13 Million - $1.61 Million	200,000 Added 6.44%	3,305,815 $23.9 Million
Q1 2024 May 15, 2024	BUY	$6.63 - $10.69 $3.38 Million - $5.45 Million	510,000 Added 19.65%	3,105,815 $25.1 Million
Q4 2023 Feb 14, 2024	SELL	$3.61 - $7.76 $4.3 Million - $9.23 Million	-1,190,014 Reduced 31.43%	2,595,815 $17.7 Million
Q3 2023 Nov 14, 2023	BUY	$4.68 - $9.26 $9.34 Million - $18.5 Million	1,995,831 Added 111.5%	3,785,829 $18.9 Million
Q2 2023 Aug 14, 2023	BUY	$8.5 - $10.38 $85,000 - $103,800	10,000 Added 0.56%	1,789,998 $16.3 Million
Q1 2023 May 15, 2023	BUY	$7.53 - $10.95 $7.71 Million - $11.2 Million	1,024,000 Added 135.45%	1,779,998 $16.8 Million
Q4 2022 Feb 14, 2023	BUY	$9.44 - $13.09 $3.12 Million - $4.33 Million	331,000 Added 77.88%	755,998 $7.54 Million
Q3 2022 Nov 14, 2022	BUY	$8.14 - $12.25 $3.46 Million - $5.21 Million	424,998 New	424,998 $5.07 Million
Q4 2021 Feb 14, 2022	SELL	$8.8 - $16.0 $1.39 Million - $2.53 Million	-158,140 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$17.8 - $23.5 $2.81 Million - $3.72 Million	158,140 New	158,140 $3.42 Million
Q1 2021 May 17, 2021	SELL	$17.18 - $22.6 $580,907 - $764,173	-33,813 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$11.5 - $17.96 $1.16 Million - $1.82 Million	-101,298 Reduced 74.97%	33,813 $605,000
Q3 2020 Nov 13, 2020	BUY	$10.62 - $13.12 $581,561 - $718,464	54,761 Added 68.15%	135,111 $1.57 Million
Q2 2020 Aug 14, 2020	BUY	$7.35 - $10.81 $38,955 - $57,293	5,300 Added 7.06%	80,350 $742,000
Q1 2020 May 15, 2020	SELL	$8.38 - $17.34 $439,112 - $908,616	-52,400 Reduced 41.11%	75,050 $781,000
Q4 2019 Feb 14, 2020	BUY	$11.18 - $18.6 $1.42 Million - $2.37 Million	127,450 New	127,450 $2.28 Million

Others Institutions Holding AXGN

# of Institutions

162

Shares Held

36.6M

Call Options Held

230K

Put Options Held

400

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $704M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.

Account

Soleus Capital Management, L.P. Axogen, Inc. Transaction History